Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rajeni, Thangarajah"'
Autor:
Luke B Snell, Adela Alcolea-Medina, Themoula Charalampous, Christopher Alder, Tom G S Williams, Flavia Flaviani, Rahul Batra, Prijay Bakrania, Rajeni Thangarajah, Stuart J D Neil, Claire van Nispen tot Pannerden, Alina Botgros, Emma Aarons, Samuel T Douthwaite, Jonathan D Edgeworth, Gaia Nebbia
Publikováno v:
Clinical Infectious Diseases. 76:1125-1128
The management of coronavirus disease 2019 has become more complex due to the expansion of available therapies. The presence of severe acute respiratory syndrome coronavirus 2 variants and mutations further complicates treatment due to their differin
Autor:
Ashwini Kurshan, Luke B Snell, Lucie Prior, Jerry C H Tam, Carl Graham, Rajeni Thangarajah, Jonathan D Edgeworth, Gaia Nebbia, Katie J Doores
Publikováno v:
Oxford Open Immunology. 4
Neutralizing monoclonal antibodies (mAbs) targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike glycoprotein have been developed for the treatment of COVID-19. Whilst antibody therapy has been shown to reduce the risk of COVID-
Autor:
Luke B, Snell, Adela, Medina-Alcolea, Themoula, Charalampous, Christopher, Alder, Tom G S, Williams, Flavia, Flaviani, Rahul, Batra, Prijay, Bakrania, Rajeni, Thangarajah, Stuart J D, Neil, Claire, van Nispen Tot Pannerden, Alina, Botgros, Emma, Aarons, Samuel T, Douthwaite, Jonathan D, Edgeworth, Gaia, Nebbia
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
The management of COVID-19 has become more complex due to the expansion of available therapies. The presence of SARS-CoV-2 variants and mutations further complicate treatment due to their differing susceptibilities to therapies. Here we outline the u
Publikováno v:
Journal of Antimicrobial Chemotherapy. 74:1757-1759